BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-19.02%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$862M
AUM Growth
+$862M
(-38%)
Cap. Flow
-$276M
Cap. Flow
% of AUM
-31.98%
Top 10 Holdings %
Top 10 Hldgs %
52.73%
Holding
87
New
4
Increased
9
Reduced
23
Closed
18
Top Buys
| 1 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$21.1M |
| 2 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$19.8M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$15.2M |
| 4 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
$13.5M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$7.18M |
Top Sells
| 1 |
Bausch Health
BHC
|
$91.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$30M |
| 3 |
CRDC
CARDICA INC COM NEW (DE)
CRDC
|
$28.4M |
| 4 |
Emergent Biosolutions
EBS
|
$26.9M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$21.7M |
Sector Composition
| 1 | Healthcare | 84.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CASM
51
DELISTED
CAS Medical Systems, Inc.
CASM
| $3.54M | 0.34% |
2,494,534
-123,762
| -5% | -$176K |
|
|
NVET
52
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $3.3M | 0.32% |
1,000,000
+278,405
| +39% | +$919K |
|
|
CRDC
53
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $3.16M | 0.31% |
887,499
-7,987,493
| -90% | -$28.4M |
|
54
SCYNEXIS
SCYX
$34.7M
| $3.04M | 0.29% |
753,373
-21,627
| -3% | -$87.2K |
|
|
EPRS
55
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $2.9M | 0.28% |
1,079,543
-295,457
| -21% | -$795K |
|
|
CFRX
56
DELISTED
ContraFect Corporation
CFRX
| $2.87M | 0.28% |
844,906
-573,533
| -40% | -$1.95M |
|
57
Protalix BioTherapeutics
PLX
$131M
| $2.85M | 0.27% |
3,386,285
+47,715
| +1% | +$40.1K |
|
58
Cidara Therapeutics
CDTX
$1.6B
| $2.12M | 0.2% |
166,875
| – | – |
|
59
Tonix Pharmaceuticals
TNXP
$244M
| $1.99M | 0.19% |
825,986
-64,762
| -7% | -$156K |
|
60
Ardelyx
ARDX
$1.55B
| $1.68M | 0.16% |
216,180
-133,110
| -38% | -$1.03M |
|
61
Phio Pharmaceuticals
PHIO
$11.6M
| $1.36M | 0.13% |
5,018,409
-108,073
| -2% | -$29.2K |
|
|
WINT
62
DELISTED
Windtree Therapeutics Inc
WINT
| $1.3M | 0.13% |
777,797
-10,111,369
| -93% | -$16.9M |
|
|
SPNC
63
DELISTED
Spectranetics Corp
SPNC
| $1.05M | 0.1% |
72,615
-492,464
| -87% | -$7.15M |
|
64
Strata Skin Sciences
SSKN
$9.01M
| $953K | 0.09% |
1,008,297
-266,000
| -21% | -$251K |
|
65
Qualigen Therapeutics
QLGN
$3.03M
| $879K | 0.08% |
778,000
| – | – |
|
66
Veracyte
VCYT
$2.39B
| $525K | 0.05% |
97,298
-207,682
| -68% | -$1.12M |
|
67
Amphastar Pharmaceuticals
AMPH
$1.38B
| – | – |
-1,026,979
| Closed | -$14.6M |
|
68
Armata Pharmaceuticals
ARMP
$92.4M
| – | – |
-552,000
| Closed | -$2.2M |
|
69
Assertio
ASRT
$78.1M
| – | – |
-725,600
| Closed | -$13.2M |
|
70
AtriCure
ATRC
$1.73B
| – | – |
-803,519
| Closed | -$18M |
|
|
71
Bausch Health
BHC
$2.73B
| – | – |
-900,000
| Closed | -$91.5M |
|
|
BLRX
72
BioLineRX
BLRX
$15.2M
| – | – |
-3,500,000
| Closed | -$4.55M |
|
|
73
Emergent Biosolutions
EBS
$432M
| – | – |
-672,922
| Closed | -$26.9M |
|
74
Fate Therapeutics
FATE
$115M
| – | – |
-1,113,986
| Closed | -$3.75M |
|
75
iShares Russell 2000 ETF
IWM
$66.5B
| – | – |
0
| – | – |
|